| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Chadwick Jeremy G | Chief Operating Officer | C/O KYMERA THERAPEUTICS, INC., 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN | /s/ Bruce Jacobs, as Attorney-in-Fact | 23 May 2025 | 0001388406 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KYMR | Common Stock | Sale | $75,436 | -2,575 | -3.7% | $29.30 | 66,420 | 23 May 2025 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the Reporting Person. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.18 to $29.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | This number includes 1,195 shares and shares acquired under the Registrant's employee stock purchase plan. |